SAHA regulates histone acetylation, butyrylation, and protein expression in neuroblastoma

Journal of Proteome Research

Volumn 13, Issue 10, 2014, Pages 4211-4219

  Xu, Guofeng ^a   Wang, Jun ^a   Wu, Zhixiang ^b   Qian, Lili ^b   Dai, Lunzhi ^c   Wan, Xuelian ^b   Tan, Minjia ^b   Zhao, Yingming ^c   Wu, Yeming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

histone deacetylase (HDAC); lysine acetylation; lysine butyrylation; neuroblastoma; quantitative proteomics; suberoylanilide hydroxamic acid (SAHA)

Indexed keywords

BIOLOGICAL MARKER; DNA; HISTONE; LYSINE; VORINOSTAT; ANTINEOPLASTIC AGENT; BUTYRIC ACID; HYDROXAMIC ACID; TUMOR PROTEIN;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOINFORMATICS; BUTYRYLATION; CELL GROWTH; CELL METABOLISM; CELL VIABILITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; GENE ONTOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURAL PROTEOMICS; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING; ACETYLATION; AMINO ACID SEQUENCE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; TUMOR CELL LINE;

ACETYLATION; AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BUTYRIC ACID; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HISTONES; HUMANS; HYDROXAMIC ACIDS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEUROBLASTOMA; TANDEM MASS SPECTROMETRY;

EID: 84907830955     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500497e     Document Type: Article

References (37)

1. Diskin, S. J.; Hou, C.; Glessner, J. T.; Attiyeh, E. F.; Laudenslager, M.; Bosse, K.; Cole, K.; Mosse, Y. P.; Wood, A.; Lynch, J. E.; Pecor, K.; Diamond, M.; Winter, C.; Wang, K.; Kim, C.; Geiger, E. A.; McGrady, P. W.; Blakemore, A. I.; London, W. B.; Shaikh, T. H.; Bradfield, J.; Grant, S. F.; Li, H.; Devoto, M.; Rappaport, E. R.; Hakonarson, H.; Maris, J. M. Copy number variation at 1q21.1 associated with neuroblastoma Nature 2009, 459 (7249) 987-991
2. Park, J. R.; Bagatell, R.; London, W. B.; Maris, J. M.; Cohn, S. L.; Mattay, K. M.; Hogarty, M.; Committee, C. O. G. N. Children's Oncology Group's 2013 blueprint for research: neuroblastoma Pediatr. Blood Cancer 2013, 60 (6) 985-993
3. Attiyeh, E. F.; London, W. B.; Mosse, Y. P.; Wang, Q.; Winter, C.; Khazi, D.; McGrady, P. W.; Seeger, R. C.; Look, A. T.; Shimada, H.; Brodeur, G. M.; Cohn, S. L.; Matthay, K. K.; Maris, J. M. Chromosome 1p and 11q deletions and outcome in neuroblastoma N. Engl. J. Med. 2005, 353 (21) 2243-2253
4. Kushner, B. H.; Kramer, K.; LaQuaglia, M. P.; Modak, S.; Yataghene, K.; Cheung, N. K. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma J. Clin. Oncol. 2004, 22 (24) 4888-4892
5. Yang, X. J.; Seto, E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention Oncogene 2007, 26 (37) 5310-5318
6. Xu, W. S.; Parmigiani, R. B.; Marks, P. A. Histone deacetylase inhibitors: molecular mechanisms of action Oncogene 2007, 26 (37) 5541-5552
7. Zhang, K.; Chen, Y.; Zhang, Z.; Zhao, Y. Identification and verification of lysine propionylation and butyrylation in yeast core histones using PTMap software J. Proteome Res. 2009, 8 (2) 900-906
8. Chen, Y.; Sprung, R.; Tang, Y.; Ball, H.; Sangras, B.; Kim, S. C.; Falck, J. R.; Peng, J.; Gu, W.; Zhao, Y. Lysine propionylation and butyrylation are novel post-translational modifications in histones Mol. Cell. Proteomics 2007, 6 (5) 812-819
9. Cheng, Z.; Tang, Y.; Chen, Y.; Kim, S.; Liu, H.; Li, S. S.; Gu, W.; Zhao, Y. Molecular characterization of propionyllysines in non-histone proteins Mol. Cell. Proteomics 2009, 8 (1) 45-52
10. Marks, P. A.; Breslow, R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug Nat. Biotechnol. 2007, 25 (1) 84-90
11. Kouzarides, T. Chromatin modifications and their function Cell 2007, 128 (4) 693-705
12. De los Santos, M.; Zambrano, A.; Aranda, A. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells Mol. Cancer Ther. 2007, 6 (4) 1425-1432
13. Fouladi, M.; Park, J. R.; Stewart, C. F.; Gilbertson, R. J.; Schaiquevich, P.; Sun, J.; Reid, J. M.; Ames, M. M.; Speights, R.; Ingle, A. M.; Zwiebel, J.; Blaney, S. M.; Adamson, P. C. Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report J. Clin. Oncol. 2010, 28 (22) 3623-3629
14. Hummel, T. R.; Wagner, L.; Ahern, C.; Fouladi, M.; Reid, J. M.; McGovern, R. M.; Ames, M. M.; Gilbertson, R. J.; Horton, T.; Ingle, A. M.; Weigel, B.; Blaney, S. M. A pediatric phase 1 trial of vorinostat and Temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study Pediatr. Blood Cancer 2013, 60 (9) 1452-1457
15. Abel, T.; Zukin, R. S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders Curr. Opin. Pharmacol. 2008, 8 (1) 57-64
16. Christensen, D. P.; Dahllof, M.; Lundh, M.; Rasmussen, D. N.; Nielsen, M. D.; Billestrup, N.; Grunnet, L. G.; Mandrup-Poulsen, T. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus Mol. Med. 2011, 17 (5-6) 378-390
17. Chen, Y.; Colak, G.; Zhao, Y. SILAC-based quantification of Sirt1-responsive lysine acetylome Methods Mol. Biol. 2013, 1077, 105-120
18. Shechter, D.; Dormann, H. L.; Allis, C. D.; Hake, S. B. Extraction, purification and analysis of histones Nat. Protoc. 2007, 2 (6) 1445-1457
19. Kim, S. C.; Sprung, R.; Chen, Y.; Xu, Y.; Ball, H.; Pei, J.; Cheng, T.; Kho, Y.; Xiao, H.; Xiao, L.; Grishin, N. V.; White, M.; Yang, X. J.; Zhao, Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey Mol. Cell 2006, 23 (4) 607-618
20. Kim, S. C.; Chen, Y.; Mirza, S.; Xu, Y.; Lee, J.; Liu, P.; Zhao, Y. A clean, more efficient method for in-solution digestion of protein mixtures without detergent or urea J. Proteome Res. 2006, 5 (12) 3446-3452
21. Wang, Y.; Yang, F.; Gritsenko, M. A.; Wang, Y.; Clauss, T.; Liu, T.; Shen, Y.; Monroe, M. E.; Lopez-Ferrer, D.; Reno, T.; Moore, R. J.; Klemke, R. L.; Camp, D. G. 2nd; Smith, R. D., Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells Proteomics 2011, 11 (10) 2019-2026
22. Chen, Y.; Zhao, W.; Yang, J. S.; Cheng, Z.; Luo, H.; Lu, Z.; Tan, M.; Gu, W.; Zhao, Y. Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways Mol. Cell. Proteomics 2012, 11 (10) 1048-1062
23. Peng, C.; Lu, Z.; Xie, Z.; Cheng, Z.; Chen, Y.; Tan, M.; Luo, H.; Zhang, Y.; He, W.; Yang, K.; Zwaans, B. M.; Tishkoff, D.; Ho, L.; Lombard, D.; He, T. C.; Dai, J.; Verdin, E.; Ye, Y.; Zhao, Y. The first identification of lysine malonylation substrates and its regulatory enzyme Mol. Cell. Proteomics 2011, 10 (12) M111012658
24. Cox, J.; Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification Nat. Biotechnol. 2008, 26 (12) 1367-1372
25. Cox, J.; Neuhauser, N.; Michalski, A.; Scheltema, R. A.; Olsen, J. V.; Mann, M. Andromeda: a peptide search engine integrated into the MaxQuant environment J. Proteome Res. 2011, 10 (4) 1794-1805
26. Chen, Y.; Kwon, S. W.; Kim, S. C.; Zhao, Y. Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra J. Proteome Res. 2005, 4 (3) 998-1005
27. Huang da, W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 2009, 4 (1) 44-57
28. Wardell, S. E.; Ilkayeva, O. R.; Wieman, H. L.; Frigo, D. E.; Rathmell, J. C.; Newgard, C. B.; McDonnell, D. P. Glucose metabolism as a target of histone deacetylase inhibitors Mol. Endocrinol. 2009, 23 (3) 388-401
29. Mitsiades, C. S.; Mitsiades, N. S.; McMullan, C. J.; Poulaki, V.; Shringarpure, R.; Hideshima, T.; Akiyama, M.; Chauhan, D.; Munshi, N.; Gu, X.; Bailey, C.; Joseph, M.; Libermann, T. A.; Richon, V. M.; Marks, P. A.; Anderson, K. C. Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (2) 540-545
30. Zhao, Y.; Fang, X.; Wang, Y.; Zhang, J.; Jiang, S.; Liu, Z.; Ma, Z.; Xu, L.; Li, E.; Zhang, K. Comprehensive Analysis for Histone Acetylation of Human Colon Cancer Cells Treated with a novel HDAC Inhibitor Curr. Pharm. Des. 2014, 20 (11) 1866-1873
31. Tan, M.; Luo, H.; Lee, S.; Jin, F.; Yang, J. S.; Montellier, E.; Buchou, T.; Cheng, Z.; Rousseaux, S.; Rajagopal, N.; Lu, Z.; Ye, Z.; Zhu, Q.; Wysocka, J.; Ye, Y.; Khochbin, S.; Ren, B.; Zhao, Y. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification Cell 2011, 146 (6) 1016-1028
32. Strahl, B. D.; Allis, C. D. The language of covalent histone modifications Nature 2000, 403 (6765) 41-45
33. Rohle, D.; Popovici-Muller, J.; Palaskas, N.; Turcan, S.; Grommes, C.; Campos, C.; Tsoi, J.; Clark, O.; Oldrini, B.; Komisopoulou, E.; Kunii, K.; Pedraza, A.; Schalm, S.; Silverman, L.; Miller, A.; Wang, F.; Yang, H.; Chen, Y.; Kernytsky, A.; Rosenblum, M. K.; Liu, W.; Biller, S. A.; Su, S. M.; Brennan, C. W.; Chan, T. A.; Graeber, T. G.; Yen, K. E.; Mellinghoff, I. K. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells Science 2013, 340 (6132) 626-630
34. Wang, F.; Travins, J.; DeLaBarre, B.; Penard-Lacronique, V.; Schalm, S.; Hansen, E.; Straley, K.; Kernytsky, A.; Liu, W.; Gliser, C.; Yang, H.; Gross, S.; Artin, E.; Saada, V.; Mylonas, E.; Quivoron, C.; Popovici-Muller, J.; Saunders, J. O.; Salituro, F. G.; Yan, S.; Murray, S.; Wei, W.; Gao, Y.; Dang, L.; Dorsch, M.; Agresta, S.; Schenkein, D. P.; Biller, S. A.; Su, S. M.; de Botton, S.; Yen, K. E. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation Science 2013, 340 (6132) 622-626
35. Goldberg, W. J.; Kadingo, R. M.; Barrett, J. N. Effects of ischemia-like conditions on cultured neurons: protection by low Na+, low Ca2+ solutions J. Neurosci. 1986, 6 (11) 3144-3151
36. Dinarello, C. A.; Fossati, G.; Mascagni, P. Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer Mol. Med. 2011, 17 (5-6) 333-352
37. Faraco, G.; Cavone, L.; Chiarugi, A. The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis Mol. Med. 2011, 17 (5-6) 442-447